RE: New Year Finance27 Dec 2019 19:43
Reasons for share price drop = mainly due to a forced seller + market worrying about funding options.
At 1p we are 1/10th of recent value = very cheap.
Since then, 2nd shift = double capacity, extension of land purchased and €350000 gift for electricity services from US state to supply an increased facility.
All in all sales can double or more to £12m fy 2020, then grow along with capacity. There is no reason why sales couldn't treble by 2012.
Now, if Woodford fund concludes selling q1 2020. Sales double, there is an argument for double share price from c 10p. If it trebled and makes a profit then we are away. 50p is possible in say 5 years. A few hurdles to get over but it is possible.
Remember, our products have high demand and have been accepted by the medical world.
Add on New Product developments and we have lots of potential for the patient investor.
Good luck all. Waiting for 4p to top slice.
It's,possible in 2020 H1 in my opinion.